Loading...
Judging by the number of folks charged with driving under influence I am guessing the penalty is rather light. Of...

Welcome competition should lower EpiPen prices

CVS-EpiPen Generic

A rival generic version of Mylan's EpiPen has been approved for sale at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers.

Loading…

Friday, August 24, 2018

A couple of years ago Washington fell into anaphylactic shock over the high cost of EpiPens, devices that shoot adrenaline into someone having an allergic reaction. But the Trump Administration this week injected some overdue competition into the market that could lower prices for millions of Americans.

On Thursday the Food and Drug Administration approved the first generic competitor to Mylan ‘s EpiPen. The competing drug is manufactured by the Israeli pharmaceutical company Teva. One might wonder why a simple spring device filled with a cheap medicine didn’t have competitors, even decades after invention.

That was one question in 2016, when Congress hauled in Mylan CEO Heather Bresch to register outrage about the more than $600 list price of a two-pack of pens, which millions of kids and adults have to keep on hand. Not everyone pays full price after rebates and discounts, and some of the shock came from insurance designs that increased out-of-pocket costs. But the sticker price had increased more than 500 percent over 10 years.

Yet if Mylan kept prices high, the company had help from the FDA. The agency had not articulated standards for a class of drugs known as “complex generics” such as inhalers, which are more fraught than proving similarity to, say, a molecule pill. Mylan thus had no direct competition, though it now sells its own generic copy.

Other injectors are on the market but a pharmacist can’t substitute these versions thanks to issues as minor as the instructions for the device, though there is no clinical distinction. Companies like Teva have spent years ensnared in FDA processes, and in the meantime Mylan could increase prices without market consequences.

Before he became the current FDA Commissioner, Scott Gottlieb told Congress in 2016 about the “Catch-22” for drugmakers: They couldn’t win approval as a generic because another injection device wasn’t exactly the same as EpiPen, but other regulations also make it hard for competitors to get branded alternatives through the FDA’s new drug approval pathway.

Dr. Gottlieb has made clarity for such complex generics a priority at the FDA, and on Thursday he called the Teva device approval part of the agency’s efforts to remove barriers to competition. The approval is particularly timely amid supply shortages of EpiPens.

On all the evidence, products face the sharpest price decline when two generics are competing with the branded version. More drugmakers will jump into a market if they see an opportunity to make money and a regulatory agency that doesn’t construct needless barriers to entry.

At the time of the EpiPen brouhaha, Hillary Clinton called for a federal “consumer response team” that would rove around and penalize companies for price spikes. The laugh-cry moment is that the Trump Administration has flirted with a response from the Clinton playbook: Importing price controls from Europe for drugs with expired patents that lack competition.

President Trump seems to think that drugs are too expensive because of unfettered markets, but the EpiPen episode is a reminder: The real culprit is often not too much freedom but big business exploiting big government to keep prices high.

The Wall Street Journal

Loading…

Humans of Greenville

@HumansofGville

Local photographer Joe Pellegrino explores Greenville to create a photographic census of its people.

Editorials

April 20, 2019

There are some, who after winning election to the General Assembly and crossing the threshold of the Legislative Building in Raleigh believe they’ve been transformed.

They acquire knowledge and insight beyond that of the hoi polloi.

That must be the only reason for the continued to raft of…

StateLegislature

April 16, 2019

The announcement that Kirstjen Nielsen was stepping down as Secretary of Homeland Security was sudden, but it wasn’t really a surprise. Never a favorite of President Trump, her days became numbered when her patron in the administration, Chief of Staff John F. Kelly, resigned in December.…

Homeland Security Secretary-1

April 15, 2019

The day before his indictment was announced last week, Robin Hayes said he was stepping down as chairman of the North Carolina Republican Party because of health issues. The next day, the public learned that what was driving Hayes from office wasn’t only his ailments, but the ill health of…

Republican Chairman

April 13, 2019

You know the game by now: A call comes into your mobile phone. A number pops up on your screen. You don’t recognize it. Your first instinct is to decline it, but what if it’s your child’s school? The auto repair guy? Something else? It’s a guessing game, and we’re the…

Kicking Robocalls-2

April 09, 2019

Walter Ginter began using heroin in the early 1970s while serving in the Army. By 1977, desperate to kick the habit, he turned to daily doses of methadone, a synthetic opioid that eases withdrawal and decreases cravings. The treatment worked.

“I have a good life today,” says Ginter, 69,…

Opioid Lawsuit New York

April 08, 2019

One of the first things we teach our children is to never, ever get into a stranger’s car.

In the age of Uber and Lyft, we all need to relearn that lesson. Along with: The later you’re out at night, the greater your chances of running into the wrong person. And: It’s always safer…

Uber Traffic Analysis

April 07, 2019

If you care about safe water for all, you should be celebrating the North Carolina Department of Environmental Quality’s decision to order Duke Energy to excavate coal ash from its power plant sites in the state. It was the right call for communities that for too long have been vulnerable to…

Duke Energy Coal Ash

April 07, 2019

As many of your readers are aware, State Treasurer Dale Folwell has chosen to forge ahead with his proposal to significantly alter the reimbursement strategy for health care providers who offer care under the State Health Plan. Citing concerns with the State Health Plan’s insolvency,…

April 06, 2019

Belatedly, it occurred to the Trump administration that closing the U.S.-Mexico border, as the president threatened, posed the risk of paralyzing manufacturing assembly lines, leaving grocery shelves bare and throwing the U.S. economy into a tailspin, if not outright recession. Bad idea.

So now the…

Trump Immigration

April 02, 2019

The U.S. Supreme Court heard a lot last week about what is wrong with the way North Carolina’s congressional districts are laid out. There were no questions about the bad or the good.

The job of the nine justices isn’t about that — only what is or isn’t constitutional. It…

Supreme Court Redistricting-1
75 stories in Editorials. Viewing 1 through 10.
«First Page   «Previous Page        
Page 1 of 8
        Next Page»   Last Page»